Actividad Investigadora
Variables Associated With the Risk of Severe Mucositis During Autologous Transplantation in Multiple Myeloma Patients.
Autores de IDIVAL
Autores ajenos al IDIVAL
- Alejo Alonso E
- González-Rodríguez AP
- Padilla I
- Sirvent Auzmendi M
- Lobo Olmedo A
- Vale López AM
- Castaño Caballero I
- Valencia E
- Melero Valentín P
- Etxeguren Urkixo I
- Luque Romero MLM
- Larreina Pérez J
- Puertas Martínez B
- Escalante Barrigón F
- Oviedo Madrid M
- Gorostidi Álvarez I
Unidades
Abstract
Autologous stem cell transplantation (ASCT) with melphalan 200 mg/m² remains a standard treatment for multiple myeloma (MM). We analyzed the incidence and risk factors associated with the development of mucositis in 1,268 MM patients who underwent ASCT between 2017 and 2022 across 13 national centers.
Datos de la publicación
- ISSN/ISSNe:
- 2152-2650, 2152-2669
- Tipo:
- Article
- Páginas:
- 50-56
- PubMed:
- 40987647
Clinical Lymphoma Myeloma & Leukemia CIG MEDIA GROUP, LP
Documentos
- No hay documentos
Filiaciones
Keywords
- Adverse effects of drug, Chemotherapy, Hematopoietic stem cell transplantation, Plasma cell neoplasm, Supportive care
Campos de Estudio
Cita
Francés I, Gea A, Tobalina A, Domínguez JJ, Alejo E, González AP, Padilla I, Sirvent M, Lobo A, Vale AM, Castaño I, Valencia E, Melero P, Etxeguren I, Luque MLM, Larreina J, Puertas B, Escalante F, Oviedo M, Bannatyne J, Gorostidi I, Puente M, Montes C, Bermúdez MA, Ocio EM. Variables Associated With the Risk of Severe Mucositis During Autologous Transplantation in Multiple Myeloma Patients. Clin. Lymphoma Myeloma Leuk. 2025. 26. (1):p. 50-56. IF:2,700. (2).
